Ironwood Spruces for IPO Bid; Joins Parade with $172M Filing

Ironwood Pharmaceuticals Inc. filed for an initial public offering, joining five other private U.S. biotechs that have filed for a public listing, as industry experts debate whether the IPO window is really opening up for drug development firms. (BioWorld Today)